Accès gratuit
Numéro
Therapie
Volume 67, Numéro 4, Juillet-Août 2012
Page(s) 295 - 300
Section Évaluation du médicament / Drug Evaluation
DOI https://doi.org/10.2515/therapie/2012047
Publié en ligne 1 novembre 2012
  1. World Alzheimer Report 2010. http://www.alz.co.uk/ [Google Scholar]
  2. Mangialasche F, Solomon A, Winblad B, et al. Alzheimer’s disease: clinical trials and drug development. Lancet Neurol 2010; 9(7): 702-16 [CrossRef] [PubMed] [Google Scholar]
  3. Alzheimer Research Forum. http://www.alzforum.org/ [Google Scholar]
  4. www.pharmacog.org [Google Scholar]
  5. Weiner MW, Veitch DP, Aisen PS, et al. The Alzheimer’s disease neuroimaging initiative: a review of papers published since its inception. Alzheimers Dement 2012 Feb; 8(1 Suppl): S1-68 [CrossRef] [PubMed] [Google Scholar]
  6. Barratt RA, Bowens SL, McCune SK, et al. The critical path initiative: leveraging collaborations to enhance regulatory science. Clin Pharmacol Ther 2012 Mar; 91(3): 380-3 [CrossRef] [PubMed] [Google Scholar]
  7. http://www-dsv.cea.fr/dsv/instituts/institut-d-imagerie-biomedicale-i2bm/services/neurospin-neurospin [Google Scholar]
  8. http://icm-institute.org/ [Google Scholar]